
Sign up to save your podcasts
Or


In this week's Talking Health, Jessica is joined by Dr Julie Greenfield from the charity Ataxia UK to discuss Ataxia, which is a collection of rare diseases that affects thousands of people in the UK, and Omaveloxolone (Omav), a new drug that has been approved in Scotland and is awaiting approval in the rest of the UK.
By Independent Media NewsIn this week's Talking Health, Jessica is joined by Dr Julie Greenfield from the charity Ataxia UK to discuss Ataxia, which is a collection of rare diseases that affects thousands of people in the UK, and Omaveloxolone (Omav), a new drug that has been approved in Scotland and is awaiting approval in the rest of the UK.